Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US
AI Today Summary
CurifyLabs, a Finnish startup, has secured $14 million in Series A funding to expand its 3D-printed personalized medicine technology in the United States. Their system enables pharmacies to automate the compounding of tailored drug doses on-site, improving speed and accuracy compared to traditional manual methods. The funding will support US market growth, supply chain development, and further research.
Covered by 1 source
AI Today publishes original summaries and links out — never the full source article.